Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-10-31

FDA Approved: RIVASTIGMINE TARTRATE — Original Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' rivastigmine tartrate as an original-application generic (ANDA) product. It is indicated for the treatment of dementia du…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine tartrate (rivastigmine tartrate)

Snippet

ORIG AP for RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)